Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPremier Foods Regulatory News (PFD)

Share Price Information for Premier Foods (PFD)

Share Price is delayed by 15 minutes
Get Live Data
199.60    -2.00 (-0.99%)
Bid:
199.40
Ask:
199.60
Spread: 0.20 (0.10%)
Market Cap: £1.72b
PFD Live PriceLast checked at - London Stock Exchange

Intraday Premier Foods Share Chart

Director/PDMR Shareholding

24 May 2011 13:14

RNS Number : 1931H
Premier Foods plc
24 May 2011
 

Replaces RNS 1878H - released 24/05/2011 12:20 - Individual in the table updated

 

Premier Foods plc (the "Company")

24 May 2011

 

NOTIFICATION OF TRANSACTIONS OF DIRECTORS AND OTHER PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES

This notification is made in accordance with DR 3.1.4R(1)(a).

 

On 23rd May 2011 (the "Grant Date") the following directors of the Company and other persons discharging managerial responsibility were granted the following awards under the Premier Foods Long Term Incentive Plan (the "Plan"):

 

Matching Share Awards

 

Matching Share Awards are structured as nil-cost options ("Options") to acquire ordinary shares of £0.01 each in the capital of the Company for nil consideration as set out below.

 

Individual

Director/PDMR

Number of shares subject to Options

Robert Schofield

Chief Executive Officer

1,407,474

Jim Smart

Chief Financial Officer

997,220

Tim Kelly

Chief Operating Officer

899,176

Brain Carlton

Group HR Director

257,430

Mark Hughes

Group Procurement Director

317,472

Andrew Peeler

Director of Finance & Business Services

198,398

Bob Spooner

Group Operations Director

433,802

Mark Vickery

Group IS & Change Director

257,578

Suzanne Wise

General Counsel & Company Secretary

354,620

Ian York

Group Sales Director

220,868

 

Matching Share Awards were granted on the condition that prior to the Grant Date an eligible employee agreed to commit an existing holding of, or interest in, ordinary shares in the Company as Investment Shares under the Plan up until the date of vesting of the Matching Share Award.

 

The Options will normally be exercisable between the third anniversary of the Grant Date and the day before the fifth anniversary of the Grant Date subject to continued employment, retention of the linked Investment Shares in the Company and the achievement of a share price based performance target.

 

Performance Share Awards

 

Performance Share Awards are structured as Options to acquire ordinary shares of £0.01 each in the capital of the Company for nil consideration as set out below.

Individual

Director/PDMR

Number of shares subject to Options

Robert Schofield

Chief Executive Officer

1,407,475

Jim Smart

Chief Financial Officer

997,223

Tim Kelly

Chief Operating Officer

899,180

Brain Carlton

Group HR Director

257,430

Jon Goldstone

Group Marketing Director

307,715

Mark Hughes

Group Procurement Director

317,472

Andrew Peeler

Director of Finance & Business Services

353,872

Bob Spooner

Group Operations Director

433,803

Mark Vickery

Group IS & Change Director

301,861

Suzanne Wise

General Counsel & Company Secretary

354,623

Ian York

Group Sales Director

430,801

 

The Options will normally be exercisable between the third anniversary of the Grant Date and the day before the fifth anniversary of the Grant Date subject to continued employment and the achievement of an earnings per share based performance target. No consideration was paid for the grant of the Performance Share Awards.

 

 

 

Suzanne Wise

General Counsel & Company Secretary

01727 815850

 

24th May 2011

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSSEFFELFFSEFI
Date   Source Headline
3rd Feb 20222:27 pmRNSDirector/PDMR Shareholding
1st Feb 20223:00 pmRNSDirector/PDMR Shareholding
1st Feb 202211:30 amRNSTotal Voting Rights
26th Jan 20227:00 amRNSNon-Executive Director Appointment
20th Jan 20227:00 amRNSTrading Statement
12th Jan 20227:00 amRNSApplication for Block Listing
11th Jan 20229:37 amRNSTotal Voting Rights
17th Dec 20212:00 pmRNSDirector/PDMR Shareholding
1st Dec 202111:55 amRNSTotal Voting Rights
16th Nov 20217:00 amRNSHalf-year Report
1st Nov 202111:30 amRNSTotal Voting Rights
29th Oct 20217:00 amRNSNew ESG Strategy
19th Oct 20217:00 amRNSNotice of Results
1st Oct 20212:00 pmRNSBlock listing Interim Review
1st Oct 202111:30 amRNSTotal Voting Rights
1st Sep 202111:55 amRNSTotal Voting Rights
13th Aug 202112:15 pmRNSDirector/PDMR Shareholding
13th Aug 202111:07 amRNSAppointment of Corporate Broker
2nd Aug 202111:55 amRNSTotal Voting Rights
27th Jul 20213:48 pmRNSDirector/PDMR Shareholding
23rd Jul 20212:36 pmRNSResult of AGM
23rd Jul 20217:00 amRNSQ1 Trading Update
1st Jul 202111:55 amRNSTotal Voting Rights
29th Jun 20217:00 amRNSChange to the 2021 AGM arrangements
18th Jun 20219:00 amRNSApplication for Block Listing
11th Jun 20213:04 pmRNSDirector/PDMR Shareholding
7th Jun 20212:42 pmRNSIssuance of Senior Secured Fixed Rate Notes
7th Jun 202111:03 amRNSNotice of AGM
1st Jun 202110:30 amRNSTotal Voting Rights
21st May 20212:32 pmRNS£330m Fixed Rate Notes coupon confirmed at 3.5%
20th May 202110:30 amRNSDirector/PDMR Shareholding
19th May 20217:00 amRNSFinal Results
11th May 202110:30 amRNSHolding(s) in Company
10th May 202110:30 amRNSHolding(s) in Company
6th May 20217:00 amRNSNotice of Results
4th May 202110:30 amRNSTotal Voting Rights
23rd Apr 202110:30 amRNSHolding(s) in Company
14th Apr 20217:00 amRNSApplication for Block Listing
1st Apr 20219:00 amRNSBlock listing Interim Review
1st Apr 20219:00 amRNSTotal Voting Rights
26th Mar 202110:30 amRNSHolding(s) in Company
18th Mar 20213:20 pmRNSHolding(s) in Company
12th Mar 20218:44 amRNSHolding(s) in Company
2nd Mar 20213:30 pmRNSDirector Declaration
1st Mar 202111:52 amRNSTotal Voting Rights
19th Feb 20217:00 amRNSDirectorate Change
18th Feb 20217:00 amRNSPartial redemption of Senior Secured Notes
12th Feb 20219:00 amRNSReduction of Capital
2nd Feb 202112:06 pmRNSDirector/PDMR Shareholding
1st Feb 20219:05 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.